Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter C Meijers

Showing results (11-20 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Heart Failure|November 5, 2016
Biomarkers to identify and prevent new-onset heart failure in the communityWouter C Meijers, Rudolf A de Boer, Jennifer E Ho
The American Journal of Pathology|July 28, 2016
Galectin-3, Cardiac Function, and FibrosisWouter C Meijers, Natalia López-Andrés, Rudolf A de Boer
Heart Failure Clinics|November 21, 2017
Galectin-3 in Heart Failure: An Update of the Last 3 YearsCarolin Gehlken, Navin Suthahar, Wouter C Meijers, et al.
EJIFCC|September 30, 2016
ST2 and Galectin-3: Ready for Prime Time?Wouter C Meijers, A Rogier van der Velde, Rudolf A de Boer
Current Heart Failure Reports|June 24, 2014
Biomarkers for risk prediction in acute decompensated heart failureA Rogier van der Velde, Wouter C Meijers, Rudolf A de Boer
Nature Cardiovascular Research|November 12, 2025
A call to action for the evolving field of cardio-oncologyReza Parvan, Joseph Pierre AbouMsallem, Wouter C Meijers, et al.
Expert Review of Molecular Diagnostics|March 11, 2014
The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failureWouter C Meijers, A Rogier van der Velde, Rudolf A de Boer
Current Heart Failure Reports|July 15, 2017
From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment OpportunitiesNavin Suthahar, Wouter C Meijers, Herman H W Silljé, et al.
JACC. Cardiooncology|August 21, 2025
Current Insights in Bidirectional Cardio-Oncology: Heart Failure Driving Cancer: JACC: CardioOncology Short-Form PrimerRudolf A de Boer, Laura I Yousif, Joseph Pierre Aboumsallem, et al.
Heart Failure Reviews|November 25, 2024
Epigenetics of cardiomyopathies: the next frontierAida Hajdarpašić, Martijn Tukker, Wouter Te Rijdt, et al.
Pageof 10

Showing results (11-20 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Heart Failure|November 5, 2016
Biomarkers to identify and prevent new-onset heart failure in the communityWouter C Meijers, Rudolf A de Boer, Jennifer E Ho
The American Journal of Pathology|July 28, 2016
Galectin-3, Cardiac Function, and FibrosisWouter C Meijers, Natalia López-Andrés, Rudolf A de Boer
Heart Failure Clinics|November 21, 2017
Galectin-3 in Heart Failure: An Update of the Last 3 YearsCarolin Gehlken, Navin Suthahar, Wouter C Meijers, et al.
EJIFCC|September 30, 2016
ST2 and Galectin-3: Ready for Prime Time?Wouter C Meijers, A Rogier van der Velde, Rudolf A de Boer
Current Heart Failure Reports|June 24, 2014
Biomarkers for risk prediction in acute decompensated heart failureA Rogier van der Velde, Wouter C Meijers, Rudolf A de Boer
Nature Cardiovascular Research|November 12, 2025
A call to action for the evolving field of cardio-oncologyReza Parvan, Joseph Pierre AbouMsallem, Wouter C Meijers, et al.
Expert Review of Molecular Diagnostics|March 11, 2014
The ARCHITECT galectin-3 assay: comparison with other automated and manual assays for the measurement of circulating galectin-3 levels in heart failureWouter C Meijers, A Rogier van der Velde, Rudolf A de Boer
Current Heart Failure Reports|July 15, 2017
From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment OpportunitiesNavin Suthahar, Wouter C Meijers, Herman H W Silljé, et al.
JACC. Cardiooncology|August 21, 2025
Current Insights in Bidirectional Cardio-Oncology: Heart Failure Driving Cancer: JACC: CardioOncology Short-Form PrimerRudolf A de Boer, Laura I Yousif, Joseph Pierre Aboumsallem, et al.
Heart Failure Reviews|November 25, 2024
Epigenetics of cardiomyopathies: the next frontierAida Hajdarpašić, Martijn Tukker, Wouter Te Rijdt, et al.
Pageof 10